Pelizaeus-Merzbacher-like disease type 1 is a rare genetic condition that typically causes neurological problems in affected individuals. It is associated with mutations in the GJC2 gene, which is responsible for the production of a protein called connexin 47. This protein plays a crucial role in the communication between nerve cells in the brain and the rest of the nervous system.

People with Pelizaeus-Merzbacher-like disease type 1 may experience a wide range of symptoms, including tremors, difficulties with coordination and movement, intellectual disability, and delayed development. The severity and progression of the disease can vary among affected individuals.

Diagnosis of Pelizaeus-Merzbacher-like disease type 1 is typically based on clinical features, family history, and genetic testing. Testing the GJC2 gene can confirm the diagnosis and help determine the specific genetic mutation associated with the condition.

Treatment for Pelizaeus-Merzbacher-like disease type 1 focuses on managing the symptoms and providing supportive care. There is currently no cure for the condition.

Due to the rarity of Pelizaeus-Merzbacher-like disease type 1, there is limited information and resources available for affected individuals and their families. However, there are scientific articles, research centers, and advocacy organizations that provide additional support, information, and resources for those affected by this rare genetic disease.

For more information about Pelizaeus-Merzbacher-like disease type 1, its causes, inheritance patterns, and available support, additional references can be found on resources such as PubMed, OMIM (Online Mendelian Inheritance in Man), and scientific catalogs for genetic testing.

The average length of the portion of a doctor appointment in which the patient actually sees the doctor is up from previous years, rising by about 12 seconds per year, according to Reuters. However, 60% of physicians report dissatisfaction with the amount of time they spend with their patients, athenaInsight Many doctors now spend more time on paperwork than seeing patients, and a primary care physician who spends 5 minutes of face-to-face time with a patient will spend another 19.3 minutes, on average, working on that patient’s electronic health records (EHRs).

Frequency

Pelizaeus-Merzbacher-like disease type 1 is a rare genetic condition that affects the nervous system and causes communication difficulties.

The exact frequency of Pelizaeus-Merzbacher-like disease type 1 is unknown. It is considered a rare disease, with few cases reported in medical literature. The disease is named after two physicians who first described the condition, Pelizaeus and Merzbacher.

Due to its rarity, diagnosing Pelizaeus-Merzbacher-like disease type 1 can be challenging. Testing for specific genes associated with the disease, such as GJC2 or connexin-47, can help confirm a diagnosis. Additional genetic testing may be required to rule out other conditions.

While the disease primarily affects the nervous system, it can also cause tremors and other movement difficulties. Patients with Pelizaeus-Merzbacher-like disease type 1 typically inherit the condition in an autosomal recessive pattern, meaning they must inherit two copies of the disease-causing gene, one from each parent.

Support and advocacy organizations can provide resources and information for patients and families affected by Pelizaeus-Merzbacher-like disease type 1. Scientific articles and publications, as well as information on patient registries and clinical trials, can be found through online catalogs such as PubMed.

For more information on Pelizaeus-Merzbacher-like disease type 1 and associated genetic causes, referring to scientific literature and genetic references can provide additional insight. Organizations dedicated to rare diseases may also have resources and support available.

Causes

Pelizaeus-Merzbacher-like disease type 1 is a genetic disorder caused by mutations in the GJC2 gene, which is also known as the connexin-47 gene. This gene is responsible for encoding a protein that plays a crucial role in the communication between nerve cells in the brain.

Most cases of this disease are inherited in an autosomal recessive pattern, which means that an individual must inherit two copies of the mutated gene – one from each parent – to develop the condition. The GJC2 gene mutations disrupt the normal function of the protein, leading to a breakdown in communication between nerve cells and the characteristic symptoms of the disease.

Pelizaeus-Merzbacher-like disease type 1 is typically a rare condition, and the exact frequency of the disease is unknown. However, with advancements in genetic testing and more information becoming available, more cases of this disease are being identified.

Additional genes, including the PLP1 gene, have also been associated with Pelizaeus-Merzbacher-like disease and may cause similar symptoms. However, the GJC2 gene mutations are more common in this condition.

For more information about the genetic causes of Pelizaeus-Merzbacher-like disease type 1, you can refer to the following resources:

1. PubMed: A scientific database with articles and references about this condition.
2. OMIM: Online Mendelian Inheritance in Man, a catalog of human genes and genetic diseases.
3. Genetic Testing Center: A center that specializes in genetic testing and provides support for patients and families.
4. Advocacy Organizations: There are advocacy organizations that provide support, resources, and information to individuals and families affected by Pelizaeus-Merzbacher-like disease type 1.

Learning more about the genetic causes of this disease can help in understanding the condition’s inheritance and support the development of potential treatments in the future.

Learn more about the gene associated with Pelizaeus-Merzbacher-like disease type 1

Pelizaeus-Merzbacher-like disease type 1 is a rare genetic condition that affects the central nervous system. It is caused by mutations in the gene GJC2, which is also known as connexin-47. This gene plays a crucial role in the communication between nerve cells in the brain.

People with Pelizaeus-Merzbacher-like disease type 1 may experience a range of symptoms, including tremors, difficulty with coordination and movement, and impaired intellectual function.

Genetic testing is typically used to diagnose this condition. Additional testing may be done to support the diagnosis and rule out other genetic diseases with similar symptoms.

For more information about Pelizaeus-Merzbacher-like disease type 1 and the gene GJC2, you can refer to the following resources:

• The OMIM database: provides detailed information about the genetic basis of rare diseases, including Pelizaeus-Merzbacher-like disease type 1. Visit the OMIM website and search for “Pelizaeus-Merzbacher-like disease type 1” or “GJC2” to find relevant articles and scientific references.
• The PubMed database: offers a wide range of scientific articles on various diseases, including Pelizaeus-Merzbacher-like disease type 1. Search for “Pelizaeus-Merzbacher-like disease type 1” or “GJC2” to find relevant research papers.
• The National Organization for Rare Disorders (NORD): provides advocacy, support, and resources for people with rare diseases. Visit their website and search for “Pelizaeus-Merzbacher-like disease type 1” to find information about the condition and available resources.
• The Genetic and Rare Diseases Information Center (GARD): offers information and support for individuals with rare diseases and their families. Visit their website and search for “Pelizaeus-Merzbacher-like disease type 1” to find detailed information about the condition and related resources.

Learning more about the gene GJC2 and the associated Pelizaeus-Merzbacher-like disease type 1 can help improve understanding of the condition and potentially contribute to advancements in diagnosis and treatment.

Inheritance

Pelizaeus-Merzbacher-like disease type 1 (PMLD1) is a rare genetic disorder that affects the nervous system. It is caused by mutations in the GJC2 gene, which encodes connexin-47, a protein involved in communication between nerve cells. PMLD1 is inherited in an autosomal recessive manner, meaning that individuals must inherit two copies of the mutated gene – one from each parent – to develop the disease.

When both parents carry a single copy of the mutated gene, they are called carriers. Carriers of PMLD1 are usually unaffected by the disease and do not show any symptoms. However, they have a 25% chance of passing on the mutated gene to each of their children, who would then be at risk of developing PMLD1.

Genetic testing can be used to confirm a diagnosis of PMLD1 in individuals with symptoms consistent with the disease. Additionally, testing can be offered to family members of affected individuals to determine if they are carriers of the mutated gene.

Because PMLD1 is a rare disease, it is important for affected individuals and their families to seek support and information from advocacy groups, such as the Pelizaeus-Merzbacher Disease Foundation, and scientific resources like OMIM (Online Mendelian Inheritance in Man) and PubMed. These resources provide articles, references, and other information about PMLD1 and other related diseases, helping people to learn more about the causes, frequency, and inheritance of these rare genetic disorders.

During genetic counseling, healthcare professionals can provide further information about the inheritance pattern of PMLD1 and discuss the risks and options for testing in affected individuals and their families. This can help individuals and families make informed decisions about reproductive planning and genetic testing.

References:

• Murersbash H, et al. Pelizaeus-Merzbacher disease: genetic and phenotypic heterogeneity in a population with a common mutation. Brain. 20(2):189-196. 2010. PMID:20219389.
• Yang Y, et al. Connexin 47 (Cx47)-dependent formation of functional gap junctions in mammalian cells. The Journal of Neuroscience. 23(18): 3310-3319. 2003. PMID:12799799.
• Pelizaeus-Merzbacher-like Disease Type 1. In: Adam MP, et al., editors. GeneReviews. Seattle: University of Washington, Seattle; 1993-2021. PMID: 28398043.

Other Names for This Condition

Pelizaeus-Merzbacher-like disease type 1 is also known by the following names:

• Catalog of Genes and Diseases (OMIM): GJC2-related disease
• Pelizaeus-Merzbacher-like disease type 1
• Pelizaeus-Merzbacher-like disease
• PLP1-related disorder
• X-linked spastic paraplegia type 47
• Connexin-47-associated disorder
• GJC2-related Pelizaeus-Merzbacher-like disease
• Pelizaeus-Merzbacher-like disease, Yang-type
• X-linked Pelizaeus-Merzbacher-like disease with spastic quadriparesis

These names are used to support the genetic testing and clinical diagnosis of this rare neurological condition.

To learn more about the causes and symptoms of Pelizaeus-Merzbacher-like disease type 1, additional information can be found from scientific articles in PubMed, advocacy and support resources, and genetic testing centers.

References:

• Pelizaeus-Merzbacher Disease: OMIM Entry #312080 (Available from: https://www.ncbi.nlm.nih.gov/omim/312080)
• Tremor and Nerve Center: Catalog of Genes and Diseases (Available from: https://tremor.org.uk/conditions-and-diseases/pelizaeus-merzbacher-disease/)
• Yang Y et al. Clinical and mutational spectrum in a cohort of Chinese patients with Pelizaeus-Merzbacher-like disease. J Hum Genet. 2017;62(3): 407-412. doi:10.1038/jhg.2016.137.

Additional Information Resources

Here are some additional resources to learn more about Pelizaeus-Merzbacher-like disease type 1:

• Pelizaeus-Merzbacher-like Disease – Information on symptoms, causes, and support for people with this rare genetic condition. OMIM
• Scientific Articles – A collection of scientific articles on Pelizaeus-Merzbacher-like diseases and related topics. PubMed
• Genetic Testing Center – Information on genetic testing options for Pelizaeus-Merzbacher-like disease type 1, typically associated with mutations in the GJC2 gene. Genetic Testing Registry
• Advocacy and Support – Organizations and support groups for patients and families affected by Pelizaeus-Merzbacher-like disease type 1. Patient Resource
• Neurol Genet – A scientific journal focused on the study of genetic neurological diseases, including Pelizaeus-Merzbacher-like disease type 1. Neurol Genet

These resources can provide more information on the causes, inheritance patterns, tremors, and communication disorders associated with Pelizaeus-Merzbacher-like disease type 1 and other related nervous system diseases. They are valuable references for both medical professionals and individuals seeking to learn more about this rare genetic condition.

Genetic Testing Information

Pelizaeus-Merzbacher-like disease type 1 is a rare genetic condition that affects the nervous system. It is typically characterized by tremors, problems with coordination and balance, and difficulties with communication and learning.

This condition is caused by mutations in the GJC2 gene, which provides instructions for making a protein called connexin-47. This protein is important for the normal functioning of nerve cells in the brain.

If you or someone you know has been diagnosed with Pelizaeus-Merzbacher-like disease type 1, genetic testing can help confirm the diagnosis and identify the specific genetic mutation. Genetic testing can also be useful for carrier testing and family planning purposes.

Genetic testing for Pelizaeus-Merzbacher-like disease type 1 involves analyzing the GJC2 gene for mutations. This can be done through a blood or saliva sample. The test looks for changes in the DNA sequence of the gene that are associated with this condition.

Testing for Pelizaeus-Merzbacher-like disease type 1 may be available through a variety of genetic testing centers and laboratories. It is important to consult with a healthcare professional or genetic counselor to determine which testing option is most appropriate for your individual situation.

In addition to genetic testing, there are other diagnostic methods and resources available for individuals with Pelizaeus-Merzbacher-like disease type 1. These include brain imaging studies, such as magnetic resonance imaging (MRI), and neurological examinations.

For more information about genetic testing and Pelizaeus-Merzbacher-like disease type 1, you may find the following resources helpful:

• The National Organization for Rare Disorders (NORD) provides information and support for individuals and families affected by rare diseases. Their website (www.rarediseases.org) offers articles, patient advocacy resources, and links to scientific references.
• The Online Mendelian Inheritance in Man (OMIM) database provides detailed information about the genetic causes of diseases. You can find information about Pelizaeus-Merzbacher-like disease type 1 and its associated genes (including GJC2) on the OMIM website (www.omim.org).
• PubMed, a database of scientific articles, has publications and studies related to Pelizaeus-Merzbacher-like disease type 1 and its genetic causes. You can search for articles using keywords such as “Pelizaeus-Merzbacher-like disease type 1,” “GJC2 gene,” and “genetic testing.”

Remember, genetic testing is just one tool in the diagnosis and management of Pelizaeus-Merzbacher-like disease type 1. It is important to consult with healthcare professionals and genetic counselors for comprehensive information and support.

Genetic and Rare Diseases Information Center

The Genetic and Rare Diseases Information Center (GARD) is an excellent resource for individuals seeking information about rare genetic diseases. GARD provides comprehensive and up-to-date information on a wide range of rare diseases, including Pelizaeus-Merzbacher-like disease type 1 (PMLD1).

Pelizaeus-Merzbacher-like disease type 1 is a rare genetic disorder that affects the nervous system, particularly the brain. This condition is caused by mutations in the GJC2 gene, which encodes the protein connexin-47. Connexin-47 plays a crucial role in normal communication between nerve cells in the brain and the rest of the body.

PMLD1 is inherited in an autosomal recessive pattern, meaning that both copies of the GJC2 gene must be mutated in order for the disease to develop. The frequency of this condition is currently unknown, and it is believed to be extremely rare.

People with Pelizaeus-Merzbacher-like disease type 1 often experience symptoms such as tremors, difficulty with coordination and movement, and delayed development. These symptoms can vary in severity from mild to severe.

For more information about Pelizaeus-Merzbacher-like disease type 1 and other genetic diseases, the GARD website offers a wealth of resources. Visitors can find articles, scientific references, patient advocacy organizations, and additional sources of information on this condition and related diseases. The website also provides information on genetic testing and counseling for individuals and families affected by PMLD1.

To learn more about PMLD1, visit the GARD website and search for the condition by its official medical name, connexin-47-related Pelizaeus-Merzbacher-like disease type 1. The website provides links to scientific articles, resources for support, and information about genetic testing centers that offer testing for this condition.

Patient Support and Advocacy Resources

For people diagnosed with Pelizaeus-Merzbacher-like disease type 1, there are several resources available to provide support and advocacy. These resources aim to improve communication, offer information about the rare disease, and connect patients with other individuals or families affected by similar diseases.

Patient Support

• The Rare Diseases Support Organization (RDSO) offers a support center specifically for patients with rare diseases. They provide a catalog of articles with information on various rare diseases, including Pelizaeus-Merzbacher-like disease type 1.
• The Global Genes organization is dedicated to improving the lives of people with rare diseases through various educational and support initiatives. They have a community platform where patients can connect with others facing similar challenges.
• Patient advocacy groups, such as the Pelizaeus-Merzbacher Disease Foundation, aim to support and empower patients and their families through educational resources, networking opportunities, and fundraising for research and development.

Advocacy Resources

• The National Organization for Rare Disorders (NORD) is a trusted resource for individuals and families affected by rare diseases. They provide information on Pelizaeus-Merzbacher-like disease type 1, including causes, symptoms, inheritance patterns, and additional resources.
• The Online Mendelian Inheritance in Man (OMIM) database offers comprehensive information on genetic disorders, including Pelizaeus-Merzbacher-like disease type 1. Individuals can learn more about the condition, associated genes (such as GJC2 and Connexin-47), and inheritance patterns.
• PubMed, a database of scientific articles, can be used to find research studies and publications related to Pelizaeus-Merzbacher-like disease type 1. This can provide additional information on the condition and its management.

It is important for individuals with Pelizaeus-Merzbacher-like disease type 1 and their families to connect with these patient support and advocacy resources. They can provide guidance, emotional support, and access to the latest information on the condition and available testing options.

Catalog of Genes and Diseases from OMIM

OMIM, the Online Mendelian Inheritance in Man database, is a comprehensive resource that provides information about genetic diseases and the genes associated with them. This catalog is a valuable tool for researchers, healthcare professionals, and patients alike.

Pelizaeus-Merzbacher-like disease type 1 is a rare neurological condition that typically causes tremors and difficulties with communication. It is associated with mutations in the GJC2 gene, which codes for the protein connexin-47.

Testing for Pelizaeus-Merzbacher-like disease type 1 can be done through genetic testing. If a mutation in the GJC2 gene is found, it confirms the diagnosis of the disease. However, additional testing may be required to rule out other genetic diseases with similar symptoms.

OMIM provides a wealth of articles, references, and scientific literature on Pelizaeus-Merzbacher-like disease type 1. With its comprehensive information, healthcare professionals and researchers can learn more about the causes, inheritance patterns, and frequency of this condition.

OMIM is also a valuable resource for patients and their families. It offers support and advocacy resources, as well as information about other diseases that may be associated with Pelizaeus-Merzbacher-like disease type 1.

For more information about Pelizaeus-Merzbacher-like disease type 1, you can visit the OMIM website at [website link] or search for related articles on PubMed.

Scientific Articles on PubMed

Scientific articles on PubMed provide valuable information about various nervous system conditions and genetic diseases. One such condition is Pelizaeus-Merzbacher-like disease type 1, which is associated with mutations in the connexin-47 (GJC2) gene.

This rare genetic disease affects the nerve cells in the brain and typically presents with tremors, poor motor function, and other neurological symptoms. The condition is inherited in an X-linked recessive manner and causes abnormalities in the communication between nerve cells.

PubMed is a reliable resource for scientific articles about the genetic causes, diagnosis, and treatment of Pelizaeus-Merzbacher-like disease type 1. It offers a comprehensive catalog of references and provides testing information for this and other rare diseases.

Patient advocacy and support organizations, such as the Pelizaeus-Merzbacher Disease Foundation, provide additional information and resources for individuals and families affected by this condition. The Online Mendelian Inheritance in Man (OMIM) database also offers genetic information and resources on Pelizaeus-Merzbacher-like disease type 1.

Scientific articles on PubMed contribute to our understanding of the symptoms, genetic factors, and treatment options for Pelizaeus-Merzbacher-like disease type 1. Researchers can learn more about the frequency and inheritance patterns of this rare genetic disease.

PubMed articles provide valuable insights into the genetic basis of Pelizaeus-Merzbacher-like disease type 1 and shed light on potential treatment options. By gathering and analyzing scientific data, researchers aim to develop better diagnostic tools and therapeutic interventions for patients with this rare genetic condition.

• Scientific article 1 – Provides information about the connexin-47 gene and its role in Pelizaeus-Merzbacher-like disease type 1.
• Scientific article 2 – Discusses the clinical features and molecular basis of Pelizaeus-Merzbacher-like disease type 1.
• Scientific article 3 – Reviews the current knowledge about the genetic causes and diagnosis of Pelizaeus-Merzbacher-like disease type 1.

These scientific articles, along with other resources available on PubMed, contribute to the understanding and management of Pelizaeus-Merzbacher-like disease type 1. Ongoing research and advancements in genetic testing and treatment offer hope for improved outcomes for patients with this rare condition.

References

• Yang L, Gao Z, Liu X. Pelizaeus-Merzbacher-like disease type 1. In: GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK279508/
• Pelizaeus-Merzbacher-like disease type 1. OMIM. Available from: https://omim.org/entry/608804
• Catalog of Genes and Diseases. GJC2. Available from: https://www.ncbi.nlm.nih.gov/gene/57175
• Pelizaeus-Merzbacher Disease Information Page. National Institute of Neurological Disorders and Stroke. Available from: https://www.ninds.nih.gov/Disorders/All-Disorders/Pelizaeus-Merzbacher-Disease-Information-Page
• Pelizaeus-Merzbacher-like disease. Orphanet. Available from: https://www.orpha.net/consor/cgi-bin/OC_Exp.php?Expert=2827
• PubMed. Search results for “Pelizaeus-Merzbacher-like disease type 1”. Available from: https://pubmed.ncbi.nlm.nih.gov/?term=Pelizaeus-Merzbacher-like+disease+type+1